| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Fatty Liver | 5 | 2021 | 299 | 1.90 | Why? |
| Insulin Resistance | 8 | 2021 | 669 | 1.14 | Why? |
| Body Fat Distribution | 1 | 2021 | 25 | 0.92 | Why? |
| Immunoglobulin lambda-Chains | 1 | 2019 | 6 | 0.81 | Why? |
| Immunoglobulin kappa-Chains | 1 | 2019 | 12 | 0.81 | Why? |
| Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2018 | 2 | 0.78 | Why? |
| Diglycerides | 1 | 2018 | 32 | 0.77 | Why? |
| Hepatic Stellate Cells | 1 | 2018 | 35 | 0.76 | Why? |
| Immunoglobulin Light Chains | 1 | 2019 | 62 | 0.75 | Why? |
| Paraproteinemias | 1 | 2019 | 61 | 0.75 | Why? |
| Fetuin-B | 1 | 2017 | 1 | 0.74 | Why? |
| alpha-2-HS-Glycoprotein | 1 | 2017 | 25 | 0.71 | Why? |
| Mitosis | 1 | 2017 | 43 | 0.69 | Why? |
| Blood Preservation | 1 | 2019 | 191 | 0.69 | Why? |
| Lipase | 1 | 2018 | 153 | 0.66 | Why? |
| Blood Cells | 1 | 2017 | 104 | 0.64 | Why? |
| Liver | 7 | 2021 | 4007 | 0.61 | Why? |
| Cryopreservation | 1 | 2019 | 464 | 0.58 | Why? |
| Everolimus | 1 | 2017 | 215 | 0.57 | Why? |
| Hemostasis | 1 | 2021 | 811 | 0.56 | Why? |
| Insulin | 7 | 2018 | 1316 | 0.48 | Why? |
| Hematologic Tests | 1 | 2017 | 521 | 0.48 | Why? |
| Diabetes Mellitus, Type 2 | 7 | 2021 | 6166 | 0.44 | Why? |
| Glycated Hemoglobin A | 2 | 2018 | 1316 | 0.41 | Why? |
| Polymorphism, Single Nucleotide | 4 | 2019 | 3607 | 0.39 | Why? |
| Infant, Premature | 4 | 2018 | 883 | 0.37 | Why? |
| Non-alcoholic Fatty Liver Disease | 4 | 2019 | 907 | 0.37 | Why? |
| Reticulocytes | 2 | 2018 | 55 | 0.36 | Why? |
| Membrane Proteins | 1 | 2018 | 1733 | 0.35 | Why? |
| Food, Fortified | 2 | 2018 | 43 | 0.35 | Why? |
| Blood Coagulation Tests | 3 | 2017 | 855 | 0.35 | Why? |
| Dabigatran | 3 | 2017 | 204 | 0.33 | Why? |
| Glucose Tolerance Test | 5 | 2019 | 238 | 0.33 | Why? |
| Diabetes Mellitus | 2 | 2020 | 8207 | 0.32 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.30 | Why? |
| Blood Glucose | 8 | 2019 | 3642 | 0.30 | Why? |
| Hypothalamus | 2 | 2017 | 58 | 0.30 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.28 | Why? |
| Acetaminophen | 2 | 2017 | 326 | 0.27 | Why? |
| Energy Metabolism | 2 | 2018 | 451 | 0.26 | Why? |
| Liver Failure, Acute | 2 | 2017 | 279 | 0.26 | Why? |
| Glucose | 2 | 2018 | 573 | 0.25 | Why? |
| Epitopes, T-Lymphocyte | 3 | 2021 | 2262 | 0.22 | Why? |
| Overweight | 2 | 2018 | 916 | 0.22 | Why? |
| Thrombin Time | 2 | 2017 | 46 | 0.22 | Why? |
| Protein S | 1 | 2021 | 150 | 0.21 | Why? |
| Protein C | 1 | 2021 | 141 | 0.21 | Why? |
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2019 | 4 | 0.21 | Why? |
| Latex | 1 | 2019 | 9 | 0.20 | Why? |
| Lipogenesis | 1 | 2019 | 49 | 0.20 | Why? |
| Hypoglycemic Agents | 3 | 2018 | 2165 | 0.19 | Why? |
| Eryptosis | 1 | 2018 | 3 | 0.19 | Why? |
| G-Protein-Coupled Receptor Kinase 5 | 1 | 2018 | 3 | 0.19 | Why? |
| T-Lymphocytes | 3 | 2021 | 6670 | 0.19 | Why? |
| Drug Monitoring | 2 | 2017 | 1408 | 0.19 | Why? |
| Cell Line, Transformed | 1 | 2018 | 87 | 0.19 | Why? |
| Biomarkers, Tumor | 2 | 2019 | 1314 | 0.19 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.19 | Why? |
| Islet Amyloid Polypeptide | 1 | 2018 | 7 | 0.19 | Why? |
| 46, XX Disorders of Sex Development | 1 | 2017 | 4 | 0.19 | Why? |
| Mullerian Ducts | 1 | 2017 | 6 | 0.18 | Why? |
| Bottle Feeding | 1 | 2018 | 28 | 0.18 | Why? |
| Fluorouracil | 1 | 2019 | 169 | 0.18 | Why? |
| Partial Thromboplastin Time | 2 | 2017 | 436 | 0.18 | Why? |
| Ceramides | 1 | 2018 | 80 | 0.18 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.18 | Why? |
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2017 | 25 | 0.18 | Why? |
| Phosphatidylserines | 1 | 2018 | 99 | 0.18 | Why? |
| Prothrombin Time | 2 | 2017 | 434 | 0.18 | Why? |
| Infant, Very Low Birth Weight | 1 | 2018 | 62 | 0.18 | Why? |
| Prediabetic State | 2 | 2017 | 200 | 0.18 | Why? |
| Ovarian Reserve | 1 | 2017 | 45 | 0.18 | Why? |
| Neostriatum | 1 | 2017 | 6 | 0.17 | Why? |
| Anti-Mullerian Hormone | 1 | 2017 | 35 | 0.17 | Why? |
| Automation | 1 | 2020 | 429 | 0.17 | Why? |
| Cardiovascular Abnormalities | 1 | 2018 | 72 | 0.17 | Why? |
| Ovulation Induction | 1 | 2017 | 58 | 0.17 | Why? |
| Gluconeogenesis | 1 | 2017 | 41 | 0.17 | Why? |
| Phosphates | 1 | 2018 | 135 | 0.17 | Why? |
| Ethanolamines | 1 | 2018 | 71 | 0.17 | Why? |
| Uterus | 1 | 2017 | 98 | 0.17 | Why? |
| Dietary Proteins | 1 | 2018 | 112 | 0.17 | Why? |
| Term Birth | 1 | 2017 | 56 | 0.17 | Why? |
| Jejunum | 1 | 2017 | 82 | 0.17 | Why? |
| Amyloid | 1 | 2018 | 156 | 0.17 | Why? |
| Carotid Intima-Media Thickness | 1 | 2018 | 179 | 0.17 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.17 | Why? |
| Thinness | 1 | 2017 | 99 | 0.16 | Why? |
| Rivaroxaban | 2 | 2017 | 467 | 0.16 | Why? |
| Protein Stability | 1 | 2019 | 756 | 0.16 | Why? |
| Congenital Abnormalities | 1 | 2017 | 170 | 0.15 | Why? |
| Fibrinolysis | 1 | 2021 | 521 | 0.15 | Why? |
| Albuminuria | 1 | 2017 | 164 | 0.15 | Why? |
| Nasal Sprays | 1 | 2018 | 234 | 0.15 | Why? |
| Amyloidosis | 1 | 2018 | 178 | 0.15 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2021 | 760 | 0.15 | Why? |
| Intra-Abdominal Fat | 1 | 2018 | 227 | 0.15 | Why? |
| Receptors, Androgen | 1 | 2017 | 212 | 0.15 | Why? |
| Factor Xa Inhibitors | 2 | 2017 | 490 | 0.15 | Why? |
| RNA, Messenger | 3 | 2018 | 5131 | 0.15 | Why? |
| Thrombelastography | 1 | 2021 | 627 | 0.14 | Why? |
| Prostate | 1 | 2017 | 283 | 0.14 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.14 | Why? |
| Parasympathetic Nervous System | 1 | 2014 | 16 | 0.14 | Why? |
| Neuroprotective Agents | 1 | 2018 | 240 | 0.14 | Why? |
| Genetic Predisposition to Disease | 3 | 2018 | 4027 | 0.14 | Why? |
| Rectal Neoplasms | 1 | 2019 | 278 | 0.14 | Why? |
| Pyridones | 2 | 2017 | 738 | 0.14 | Why? |
| Fetal Blood | 2 | 2018 | 573 | 0.14 | Why? |
| Immunologic Memory | 3 | 2021 | 3362 | 0.14 | Why? |
| Blood Cell Count | 2 | 2017 | 1101 | 0.14 | Why? |
| Coronaviridae | 1 | 2021 | 923 | 0.14 | Why? |
| Catechin | 1 | 2018 | 244 | 0.14 | Why? |
| Receptors, Urokinase Plasminogen Activator | 1 | 2017 | 252 | 0.13 | Why? |
| Cholesterol, LDL | 1 | 2018 | 499 | 0.13 | Why? |
| Pancreas | 1 | 2018 | 398 | 0.13 | Why? |
| Quality Control | 1 | 2018 | 628 | 0.13 | Why? |
| Hepcidins | 1 | 2014 | 97 | 0.13 | Why? |
| Hemoglobins | 2 | 2017 | 958 | 0.13 | Why? |
| Enteral Nutrition | 1 | 2017 | 320 | 0.13 | Why? |
| Uric Acid | 1 | 2017 | 285 | 0.13 | Why? |
| RNA, Small Interfering | 1 | 2018 | 817 | 0.13 | Why? |
| Chromatography, Liquid | 1 | 2017 | 640 | 0.13 | Why? |
| Bone Marrow | 1 | 2017 | 492 | 0.13 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.13 | Why? |
| Diabetes, Gestational | 1 | 2018 | 426 | 0.12 | Why? |
| Hemodynamics | 2 | 2018 | 1562 | 0.12 | Why? |
| Parturition | 1 | 2017 | 514 | 0.12 | Why? |
| Cross Reactions | 2 | 2021 | 4374 | 0.12 | Why? |
| Humans | 45 | 2021 | 930598 | 0.12 | Why? |
| Biopsy | 2 | 2018 | 2811 | 0.12 | Why? |
| Obesity | 3 | 2019 | 7388 | 0.12 | Why? |
| Chemokines | 1 | 2018 | 1095 | 0.12 | Why? |
| Anemia, Iron-Deficiency | 1 | 2014 | 210 | 0.11 | Why? |
| Central Nervous System | 1 | 2017 | 701 | 0.11 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.11 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.11 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 526 | 0.11 | Why? |
| Kidney Failure, Chronic | 2 | 2018 | 3222 | 0.11 | Why? |
| Tandem Mass Spectrometry | 1 | 2017 | 1031 | 0.11 | Why? |
| Biomarkers | 6 | 2021 | 23361 | 0.10 | Why? |
| Magnetic Resonance Imaging | 4 | 2021 | 6551 | 0.10 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.10 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2017 | 676 | 0.10 | Why? |
| Pyrazoles | 2 | 2017 | 1791 | 0.10 | Why? |
| Male | 26 | 2021 | 367725 | 0.10 | Why? |
| Anemia | 1 | 2017 | 789 | 0.10 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.10 | Why? |
| Female | 25 | 2021 | 380317 | 0.10 | Why? |
| Heart Rate | 2 | 2018 | 1527 | 0.09 | Why? |
| Proteins | 1 | 2017 | 921 | 0.09 | Why? |
| Diagnostic Imaging | 1 | 2017 | 1044 | 0.09 | Why? |
| Middle Aged | 17 | 2021 | 270681 | 0.09 | Why? |
| Case-Control Studies | 5 | 2018 | 17671 | 0.09 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.09 | Why? |
| Peptides | 1 | 2020 | 2513 | 0.09 | Why? |
| Reproducibility of Results | 3 | 2020 | 11304 | 0.09 | Why? |
| Antioxidants | 1 | 2018 | 1593 | 0.09 | Why? |
| Aged | 13 | 2021 | 215776 | 0.09 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.09 | Why? |
| Placenta | 1 | 2018 | 1531 | 0.09 | Why? |
| Glycolysis | 2 | 2019 | 208 | 0.09 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.08 | Why? |
| Glucose Clamp Technique | 2 | 2017 | 39 | 0.08 | Why? |
| New York City | 1 | 2020 | 7432 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Hospitalization | 1 | 2017 | 54280 | 0.08 | Why? |
| Brain | 3 | 2018 | 5133 | 0.08 | Why? |
| Anticoagulants | 2 | 2017 | 9563 | 0.08 | Why? |
| Functional Neuroimaging | 2 | 2017 | 86 | 0.07 | Why? |
| Adult | 18 | 2021 | 244371 | 0.07 | Why? |
| Triglycerides | 2 | 2019 | 478 | 0.07 | Why? |
| Dietary Supplements | 1 | 2018 | 2251 | 0.07 | Why? |
| Sleep | 1 | 2018 | 2695 | 0.07 | Why? |
| Immunoassay | 2 | 2021 | 4485 | 0.07 | Why? |
| Prostatic Neoplasms | 1 | 2017 | 1637 | 0.07 | Why? |
| Germany | 2 | 2017 | 9196 | 0.07 | Why? |
| Mice | 3 | 2019 | 21357 | 0.07 | Why? |
| Antithrombins | 2 | 2017 | 353 | 0.07 | Why? |
| Blood Coagulation Disorders | 1 | 2017 | 2040 | 0.06 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.06 | Why? |
| Point-of-Care Systems | 1 | 2017 | 2955 | 0.06 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.06 | Why? |
| Fasting | 2 | 2018 | 555 | 0.06 | Why? |
| Oxygen Consumption | 2 | 2017 | 711 | 0.06 | Why? |
| Neutrophils | 1 | 2019 | 5476 | 0.06 | Why? |
| Weight Gain | 2 | 2017 | 552 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Administration, Intranasal | 2 | 2018 | 1132 | 0.06 | Why? |
| Lipids | 2 | 2018 | 1079 | 0.06 | Why? |
| Mice, Transgenic | 2 | 2019 | 2739 | 0.05 | Why? |
| Peptide Mapping | 1 | 2021 | 112 | 0.05 | Why? |
| Renal Dialysis | 1 | 2018 | 4358 | 0.05 | Why? |
| Gestational Age | 2 | 2018 | 1488 | 0.05 | Why? |
| Phosphoproteins | 2 | 2021 | 4346 | 0.05 | Why? |
| Specimen Handling | 1 | 2018 | 6190 | 0.05 | Why? |
| Animals | 6 | 2019 | 78931 | 0.05 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.05 | Why? |
| Gene Knock-In Techniques | 1 | 2019 | 124 | 0.05 | Why? |
| Chemoradiotherapy, Adjuvant | 1 | 2019 | 69 | 0.05 | Why? |
| Acoustic Stimulation | 1 | 2018 | 20 | 0.05 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
| Sleep Stages | 1 | 2018 | 52 | 0.05 | Why? |
| Cytochrome P450 Family 7 | 1 | 2017 | 1 | 0.05 | Why? |
| Calorimetry, Indirect | 1 | 2018 | 49 | 0.05 | Why? |
| Predictive Value of Tests | 3 | 2021 | 9537 | 0.05 | Why? |
| Cholestanetriol 26-Monooxygenase | 1 | 2017 | 12 | 0.05 | Why? |
| Chromogenic Compounds | 1 | 2017 | 10 | 0.05 | Why? |
| Receptor, Insulin | 1 | 2017 | 18 | 0.05 | Why? |
| Fatty Acids, Nonesterified | 1 | 2018 | 60 | 0.05 | Why? |
| Receptor, IGF Type 1 | 1 | 2017 | 24 | 0.05 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
| Estrogen Receptor beta | 1 | 2017 | 14 | 0.05 | Why? |
| Milk, Human | 2 | 2018 | 956 | 0.05 | Why? |
| Glutamate Carboxypeptidase II | 1 | 2017 | 24 | 0.05 | Why? |
| Proinsulin | 1 | 2017 | 9 | 0.05 | Why? |
| Reticulocyte Count | 1 | 2017 | 7 | 0.05 | Why? |
| Steroid Hydroxylases | 1 | 2017 | 23 | 0.05 | Why? |
| Diet, High-Fat | 1 | 2019 | 161 | 0.04 | Why? |
| Swine | 2 | 2017 | 3352 | 0.04 | Why? |
| Dose-Response Relationship, Drug | 2 | 2018 | 3776 | 0.04 | Why? |
| Hyperandrogenism | 1 | 2017 | 36 | 0.04 | Why? |
| HLA-DR Antigens | 1 | 2020 | 563 | 0.04 | Why? |
| Deuterium | 1 | 2017 | 21 | 0.04 | Why? |
| Anthropometry | 1 | 2018 | 233 | 0.04 | Why? |
| Ki-67 Antigen | 1 | 2017 | 139 | 0.04 | Why? |
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 198 | 0.04 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.04 | Why? |
| Lysophospholipids | 1 | 2018 | 74 | 0.04 | Why? |
| Proton Magnetic Resonance Spectroscopy | 1 | 2018 | 159 | 0.04 | Why? |
| Intracranial Pressure | 1 | 2017 | 90 | 0.04 | Why? |
| Sphingosine | 1 | 2018 | 101 | 0.04 | Why? |
| Kallikreins | 1 | 2017 | 158 | 0.04 | Why? |
| Molecular Conformation | 1 | 2018 | 374 | 0.04 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.04 | Why? |
| Norepinephrine | 1 | 2017 | 152 | 0.04 | Why? |
| Polysomnography | 1 | 2018 | 296 | 0.04 | Why? |
| Kidney Transplantation | 1 | 2017 | 5397 | 0.04 | Why? |
| Antigens, Surface | 1 | 2017 | 181 | 0.04 | Why? |
| Prostate-Specific Antigen | 1 | 2017 | 213 | 0.04 | Why? |
| Trophoblasts | 1 | 2018 | 237 | 0.04 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2021 | 724 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2021 | 813 | 0.04 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.04 | Why? |
| Solubility | 1 | 2017 | 382 | 0.04 | Why? |
| Erythrocyte Indices | 1 | 2017 | 207 | 0.04 | Why? |
| Neoadjuvant Therapy | 1 | 2019 | 554 | 0.04 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.04 | Why? |
| Histocompatibility Antigens Class I | 1 | 2020 | 624 | 0.04 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2019 | 17020 | 0.04 | Why? |
| Hemofiltration | 1 | 2017 | 155 | 0.04 | Why? |
| Polycystic Ovary Syndrome | 1 | 2017 | 151 | 0.04 | Why? |
| Infant, Newborn | 4 | 2018 | 23105 | 0.04 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.04 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Inflammation Mediators | 2 | 2018 | 2654 | 0.04 | Why? |
| Endpoint Determination | 1 | 2017 | 344 | 0.04 | Why? |
| Lactic Acid | 1 | 2018 | 393 | 0.04 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.04 | Why? |
| Portal Vein | 1 | 2017 | 193 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Body Composition | 1 | 2018 | 414 | 0.03 | Why? |
| Occupations | 1 | 2020 | 733 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2019 | 1654 | 0.03 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.03 | Why? |
| Graft Survival | 1 | 2017 | 587 | 0.03 | Why? |
| Enterococcus faecalis | 1 | 2014 | 126 | 0.03 | Why? |
| Ultrasonography, Doppler | 1 | 2017 | 406 | 0.03 | Why? |
| Cell Membrane | 1 | 2018 | 743 | 0.03 | Why? |
| Antigens, CD | 1 | 2018 | 984 | 0.03 | Why? |
| Infant, Low Birth Weight | 1 | 2014 | 243 | 0.03 | Why? |
| Lipid Metabolism | 1 | 2017 | 572 | 0.03 | Why? |
| Birth Weight | 1 | 2014 | 250 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.03 | Why? |
| Cattle | 1 | 2017 | 1336 | 0.03 | Why? |
| Fetal Growth Retardation | 1 | 2014 | 217 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2019 | 1999 | 0.03 | Why? |
| Prospective Studies | 4 | 2018 | 43301 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.03 | Why? |
| Body Weight | 1 | 2017 | 1074 | 0.03 | Why? |
| Reference Values | 1 | 2014 | 795 | 0.03 | Why? |
| Electroencephalography | 1 | 2018 | 1242 | 0.03 | Why? |
| Cerebrovascular Circulation | 1 | 2014 | 340 | 0.03 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.03 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2014 | 323 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2019 | 10998 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2014 | 1224 | 0.03 | Why? |
| Drug Overdose | 1 | 2017 | 583 | 0.02 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.02 | Why? |
| Plant Extracts | 1 | 2021 | 1514 | 0.02 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.02 | Why? |
| Cognition | 1 | 2018 | 1394 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2019 | 4758 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2017 | 1956 | 0.02 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
| Thrombolytic Therapy | 1 | 2017 | 2218 | 0.02 | Why? |
| Pregnancy | 2 | 2018 | 23879 | 0.02 | Why? |
| Ferritins | 1 | 2014 | 2055 | 0.02 | Why? |
| Delivery, Obstetric | 1 | 2014 | 1292 | 0.02 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| Point-of-Care Testing | 1 | 2017 | 2782 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2017 | 3755 | 0.02 | Why? |
| Models, Molecular | 1 | 2018 | 7616 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2017 | 2093 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2014 | 5440 | 0.02 | Why? |
| Odds Ratio | 1 | 2014 | 5861 | 0.01 | Why? |
| Emergencies | 1 | 2017 | 4095 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
| Treatment Outcome | 2 | 2019 | 51732 | 0.01 | Why? |
| Protein Binding | 1 | 2018 | 11430 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.01 | Why? |
| Logistic Models | 1 | 2014 | 9089 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.01 | Why? |
| Sepsis | 1 | 2014 | 3517 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Age Factors | 1 | 2014 | 21039 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |